Rheumatoid Arthritis Clinical Trials in Los Angeles

Showing 441-460 of 3,190 trials

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

NCT04928677

The purpose of this study to find out whether codrituzumab is a safe treatment that causes few or mild side effects in children and young adults who have solid tumors that express the protein GPC3. The researchers also want to study the way codrituzumab is absorbed, distributed, and cleared from the body.

Primary Extra-cranial Solid TumorRecurrent or Refractory Glypican 3 (GPC3)

Memorial Sloan Kettering Cancer Center50 participantsStarted Jun 2021

Los Angeles, California, United States • Atlanta, Georgia, United States • Boston, Massachusetts, United States +2 more locations

Active Not RecruitingNA< 1 mile

Eliminating Monitor Overuse Trial (EMO Trial)

NCT05132322

The purpose of this study is to identify the optimal deimplementation strategies for an overused practice: continuous pulse oximetry monitoring of children hospitalized with bronchiolitis who are not receiving supplemental oxygen.

Bronchiolitis Acute Viral

Children's Hospital of Philadelphia9,265 participantsStarted Dec 2021

Birmingham, Alabama, United States • Davis, California, United States • Encinitas, California, United States +48 more locations

A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment

Eliminating Monitor Overuse Trial (EMO Trial)

Rheumatoid Arthritis Trials in Other Cities

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)

Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy

A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

A Study to Evaluate the Safety of a Delivery Device for Administering LCTOPC1 in Participants With Spinal Cord Injury

Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough

Belimumab With Rituximab for Primary Membranous Nephropathy

Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL

Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004)

Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route

Study Of NOVOTTF-200A In Bevacizumab-Naive Subjects With Recurrent Grade III Malignant Astrocytoma

A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

A Study of AZD0120 in Autoimmune Diseases

Evaluate the Continued Safety and Performance of the Foot and Ankle Products

Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial

Other Conditions in Los Angeles